Ioforminol

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIoforminol
Drug Alias NameFEK-256062GE-145AN-113111
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionTomography enhancers
TargetsNot applicable
Therapy Area/IndicationsDiabetes MellitusHeart FailureRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe HealthcareDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGe Healthcare
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusHeart FailureRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksKEGG